Skip to main content
GemVax & KAEL Co.,Ltd. logo

GemVax & KAEL Co.,Ltd. — Investor Relations & Filings

Ticker · 082270 ISIN · KR7082270000 KO Manufacturing
Filings indexed 651 across all filing types
Latest filing 2019-07-09 Regulatory Filings
Country KR South Korea
Listing KO 082270

About GemVax & KAEL Co.,Ltd.

https://gemvax.com/

GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.

Recent filings

Filing Released Lang Actions
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent for a pharmaceutical composition. It does not fit into financial reporting, governance, or shareholder meeting categories. As it is a specific regulatory announcement regarding company operations (patent acquisition) that does not fall into the other specialized categories, it is classified as a general regulatory filing.
2019-07-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and special relationships of major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-07-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the share ownership, changes in holdings, and special relationships of the reporting entity (Gem & Company) and its special related parties regarding the issuer (GemVax & KAEL). This falls under the category of Major Shareholding Notification.
2019-06-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea for reporting insider trading or changes in share ownership by company directors and executives. Based on the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2019-06-17 Korean
기타경영사항(특허권취득)(자율공시)(골수-유래 억제세포 저해용 조성물(대만))
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from GemVax regarding the acquisition of a patent in Taiwan. It follows the standard format for a corporate disclosure of a material event (patent acquisition). Since it does not fit into specific categories like financial reports, shareholder meetings, or management changes, and is a formal regulatory announcement, it is classified as a Regulatory Filing (RNS).
2019-06-12 Korean
기타경영사항(특허권취득)(자율공시)(항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물(대만))
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by GemVax & Kael. It details the patent name, content, patent holder, and acquisition date. Since this is a specific corporate announcement regarding a business development (patent acquisition) that does not fit into financial reporting, M&A, or governance categories, it falls under the general regulatory filing category.
2019-06-05 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.